KIROVYZE

Serial Number 97714234
732

Registration Progress

Application Filed
Dec 12, 2022
Under Examination
Dec 19, 2023
Approved for Publication
Oct 24, 2023
Published for Opposition
Oct 24, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 3 Granted
Due: Dec 19, 2025 44 days

Trademark Image

KIROVYZE

Basic Information

Serial Number
97714234
Filing Date
December 12, 2022
Published for Opposition
October 24, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
732
Status Date
May 21, 2025
Application
Pending
Classes
005

Rights Holder

Bridgebio Pharma, Inc.

03
Address
3160 Porter Dr.
Palo Alto, CA 94304

Ownership History

Bridgebio Pharma, Inc.

Original Applicant
03
Palo Alto, CA

Bridgebio Pharma, Inc.

Owner at Publication
03
Palo Alto, CA

Legal Representation

Attorney
Jessica L. Rothstein

USPTO Deadlines

Next Deadline
44 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
December 19, 2025
Extension Available
Until December 19, 2024

Application History

21 events
Date Code Type Description Documents
May 22, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 21, 2025 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 21, 2025 EXT3 S SOU EXTENSION 3 FILED Loading...
May 21, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 2, 2024 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 2, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 29, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Nov 8, 2024 EXT2 S SOU EXTENSION 2 FILED Loading...
Nov 8, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 23, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 22, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 22, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 22, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 19, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 24, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 24, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 4, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 18, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 15, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 15, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 15, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals for use in the treatment of oncological, cardiological, dermatological, neurological, genetic, orthopedic and metabolic diseases and disorders

Classification

International Classes
005